FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology and can be used for treatment of open-angle glaucoma of I-II stages. For this purpose neuroprotectors are includes into standard complex of pharmacotherapy. As neuroprotectors used are 2-ethyl-6-methyl-3-hydroxypyridine succinate in dose 300 mg/day and picamilon in dose 150 mg/day.
EFFECT: method ensures expressed reduction of intraocular pressure up to its normalisation.
3 cl, 1 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 | 
 | RU2578953C1 | 
| METHOD OF IMPROVEMENT OF VISUAL FUNCTIONS AT PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALISED INTRAOCULAR TENSION | 2007 | 
 | RU2351299C1 | 
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 | 
 | RU2622759C1 | 
| METHOD OF TREATING PRIMARY GLAUCOMA IN PATIENTS WITH ACCOMPANYING ARTERIAL HYPERTENSION | 2015 | 
 | RU2607291C1 | 
| METHOD OF TREATING ELDERLY AND SENILE GLAUCOMA OPTIC NEUROPATHY | 2009 | 
 | RU2411033C1 | 
| METHOD FOR DIAGNOSING THE NEED TO PRESCRIBE GLUCOCORTICOIDS SYSTEMICALLY IN PATIENTS WITH RHEUMATIC DISEASE | 2021 | 
 | RU2760260C1 | 
| METHOD OF TREATMENT GLAUCOMATOUS OPTIC NEUROPATHY | 2015 | 
 | RU2577763C1 | 
| METHOD FOR IMPROVING VISION FUNCTION IN THE CASES OF PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALIZED OPHTHALMIC TONUS | 2003 | 
 | RU2259203C2 | 
| METHOD FOR TREATING THE CASES OF OPEN ANGLE GLAUCOMA | 1997 | 
 | RU2145826C1 | 
| METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 | 
 | RU2681654C1 | 
Authors
Dates
2013-10-10—Published
2011-12-23—Filed